Charles River Laboratories International, Inc (CRL) Sec Form 8K
Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 8K
18 articles, transcripts, and reports
Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 8K
Charles River Laboratories International, Inc (NYSE: CRL) FY 2026 Other Release
Charles River Laboratories International, Inc (NYSE: CRL) Q4 2025 Earnings Call dated Feb. 18, 2026 Corporate Participants: Todd Spencer —...
Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 10K
Charles River Laboratories International, Inc (NYSE: CRL) Sec Form 8K
Charles River Laboratories International, Inc. (NYSE: CRL), a provider of products and services for pharma companies to accelerate drug discovery...
Charles River Laboratories International, Inc (NYSE: CRL) FY 2026 Management Update
Charles River Laboratories International, Inc (NYSE: CRL) Q4 2025 Earnings Conference
Charles River Laboratories International, Inc (NYSE: CRL) Q4 2025 Earnings Release
Charles River Laboratories International, Inc (NYSE: CRL) FY 2026 Other Release